응고 검사 시장 규모, 점유율, 성장 분석 : 제품별, 검사별, 기술별, 용도별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Coagulation Testing Market Size, Share, and Growth Analysis, By Product (Instruments, Consumables), By Test (Complete Blood Count (CBC), Factor V Assay), By Technology, By Application, By End-User, By Region - Industry Forecast 2025-2032
상품코드:1687540
리서치사:SkyQuest Technology Consulting Pvt. Ltd.
발행일:2025년 03월
페이지 정보:영문 219 Pages
라이선스 & 가격 (부가세 별도)
한글목차
응고 검사 시장 규모는 2023년에 38억 달러로 평가되며, 2024년 42억 6,000만 달러에서 2032년에는 107억 1,000만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 12.2%로 성장할 전망입니다.
세계 응고 검사 시장은 심혈관 질환의 유병률 증가, 혈액 질환, 고령화 등 다양한 요인으로 인해 강력한 성장세를 보이고 있습니다. 혈우병 및 폰 빌레브란트병과 같은 질환의 유병률 증가는 응고 검사 서비스에 대한 수요를 크게 증가시키고 있습니다. 또한 수술 및 외상 증가로 인해 적시에 정확한 응고 진단이 필요하게 되었습니다. 그러나 엄격한 규제 요건은 시장 역학에 큰 영향을 미치고 있으며, 신규 진출기업에게 도전이 되고 있습니다. 품질 기준을 준수하고 규제 당국의 승인을 획득하는 것은 이 분야에서 발판을 마련하고자 하는 시장 진출기업에게 중요한 요소입니다. 전반적으로 응고 검사 시장은 이러한 변화하는 헬스케어 수요에 따라 지속적으로 성장할 수 있는 태세를 갖추고 있습니다.
목차
서론
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차와 1차 데이터 방법
시장 규모 예측
시장의 전제조건과 제한
개요
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
촉진요인과 기회
억제요인과 과제
Porter의 산업 분석
주요 시장 인사이트
주요 성공 요인
경쟁의 정도
주요 투자 기회
시장 에코시스템
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
응고 검사 시장 규모 : 제품별 & CAGR(2025-2032)
시장 개요
기기
소모품
시약과 표준
컨트롤
의료용 교정
응고 검사 시장 규모 : 검사별 & CAGR(2025-2032)
시장 개요
전혈구수(CBC)
제V 인자 어세이
피브리노겐 레벨
프로트롬빈 시간
혈소판수
트롬빈 시간
출혈 시간
기타
응고 검사 시장 규모 : 기술별 & CAGR(2025-2032)
시장 개요
광학 기술
기계 기술
전기화학 기술
기타
응고 검사 시장 규모 : 용도별 & CAGR(2025-2032)
시장 개요
활성화 응고 시간(ACT)
트롬빈 시간(TT)
부분 트롬보플라스틴 시간(PTT)
활성화 부분 트롬보플라스틴 시간(APTT)
프로트롬빈 시간(PT)
기타
응고 검사 시장 규모 : 최종사용자별 & CAGR(2025-2032)
시장 개요
병원
임상 검사실
POC(Point of Care) 검사
기타
응고 검사 시장 규모 : 지역별 & CAGR(2025-2032)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽 지역
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카 지역
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
상위 5사의 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
최근 시장 동향
기업의 시장 점유율 분석(2024년)
주요 기업의 기업 개요
기업의 상세
제품 포트폴리오 분석
기업의 부문별 점유율 분석
매출의 전년대비 비교(2022-2024)
주요 기업 개요
Roche Diagnostics(Switzerland)
Siemens Healthineers(Germany)
Abbott Laboratories(USA)
Instrumentation Laboratory(Werfen)(Spain)
Sysmex Corporation(Japan)
Thermo Fisher Scientific Inc.(USA)
bioMerieux S.A.(France)
Diagnostica Stago SAS(France)
Horiba, Ltd.(Japan)
Alere Inc.(USA)(now Abbott)
Haemonetics Corporation(USA)
Helena Laboratories Corporation(USA)
Medtronic plc(Ireland)
Agilent Technologies, Inc.(USA)
Sekisui Diagnostics(Japan)
Trinity Biotech plc(Ireland)
Kyowa Medex Co., Ltd.(Japan)
Maccura Biotechnology Co., Ltd.(China)
결론과 제안
KSA
영문 목차
영문목차
Coagulation Testing Market size was valued at USD 3.8 billion in 2023 and is poised to grow from USD 4.26 billion in 2024 to USD 10.71 billion by 2032, growing at a CAGR of 12.2% during the forecast period (2025-2032).
The global Coagulation Testing Market is experiencing robust growth, fueled by various factors including the rising incidence of cardiovascular diseases, blood disorders, and an aging population. The increased prevalence of conditions like hemophilia and von Willebrand disease has significantly heightened the demand for coagulation testing services. Moreover, the escalation in surgical procedures and trauma cases necessitates timely and accurate coagulation diagnostics. However, stringent regulatory requirements highly influence the market dynamics, posing entry challenges for new players. Compliance with quality standards and obtaining regulatory approvals are critical elements for market participants hoping to establish a foothold in this expanding sector. Overall, the coagulation testing market is poised for continued growth amid these evolving healthcare demands.
Top-down and bottom-up approaches were used to estimate and validate the size of the Coagulation Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Coagulation Testing Market Segments Analysis
Global Coagulation Testing Market is segmented by Product, Test, Technology, Application, End-User and region. Based on Product, the market is segmented into Instruments, Consumables, Reagents And Standards, Controls and Calibrations. Based on Test, the market is segmented into Complete Blood Count (CBC), Factor V Assay, Fibrinogen Level, Prothrombin Time, Platelet Count, Thrombin Time, Bleeding Time and Others. Based on Technology, the market is segmented into Optical Technology, Mechanical Technology, Electrochemical Technology and Others. Based on Application, the market is segmented into Activated Clotting Time (ACT), Thrombin Time (TT), Partial Thromboplastin Time (PTT), Activated Partial Thromboplastin Time (APTT), Prothrombin Time (PT) and Other. Based on End-User, the market is segmented into Hospitals, Clinical Laboratories, Point-of-Care Testing and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Coagulation Testing Market
The rising incidence of cardiovascular diseases, along with a globally aging population, highlights the increasing demand for coagulation testing as a critical diagnostic instrument. Furthermore, technological advancements in diagnostic methods, such as optical and electrochemical coagulation testing techniques, significantly improve the precision and efficiency of results. This progress is fueling the widespread adoption of coagulation testing across various healthcare environments, making it an essential component for effective patient management. As healthcare providers seek reliable tools for diagnosing and monitoring coagulation disorders, the market for these testing methods continues to expand, reflecting the need for enhanced patient care and outcomes.
Restraints in the Coagulation Testing Market
A significant restraint in the coagulation testing market is the inherent complexities involved in standardizing testing procedures, particularly due to variations in results obtained in different laboratories and clinical environments. These discrepancies create challenges for healthcare professionals who must interpret the results accurately, potentially compromising the overall reliability of coagulation tests. Such inconsistencies not only impede effective diagnosis and treatment but also undermine confidence in testing protocols, ultimately affecting patient care. Addressing these variations is essential to enhance the consistency and accuracy of coagulation testing across diverse healthcare settings.
Market Trends of the Coagulation Testing Market
The coagulation testing market is experiencing a significant shift towards point-of-care (POC) testing, driven by the increasing demand for rapid and decentralized diagnostic solutions. This trend is primarily motivated by the need for swift decision-making in emergency situations and outpatient care settings. Technological advancements are enhancing the development of portable, user-friendly coagulation testing devices, making them easier to adopt across diverse healthcare environments. As healthcare providers seek to improve patient outcomes through timely interventions, the growing preference for POC testing is expected to shape the future landscape of the coagulation testing market, fostering innovation and expanding accessibility.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Global Coagulation Testing Market Size by Product & CAGR (2025-2032)
Market Overview
Instruments
Consumables
Reagents And Standards
Controls
Calibrations
Global Coagulation Testing Market Size by Test & CAGR (2025-2032)
Market Overview
Complete Blood Count (CBC)
Factor V Assay
Fibrinogen Level
Prothrombin Time
Platelet Count
Thrombin Time
Bleeding Time
Others
Global Coagulation Testing Market Size by Technology & CAGR (2025-2032)
Market Overview
Optical Technology
Mechanical Technology
Electrochemical Technology
Others
Global Coagulation Testing Market Size by Application & CAGR (2025-2032)
Market Overview
Activated Clotting Time (ACT)
Thrombin Time (TT)
Partial Thromboplastin Time (PTT)
Activated Partial Thromboplastin Time (APTT)
Prothrombin Time (PT)
Other
Global Coagulation Testing Market Size by End-User & CAGR (2025-2032)
Market Overview
Hospitals
Clinical Laboratories
Point-of-Care Testing
Others
Global Coagulation Testing Market Size & CAGR (2025-2032)
North America (Product, Test, Technology, Application, End-User)
US
Canada
Europe (Product, Test, Technology, Application, End-User)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Product, Test, Technology, Application, End-User)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Product, Test, Technology, Application, End-User)
Brazil
Rest of Latin America
Middle East & Africa (Product, Test, Technology, Application, End-User)
